Cited by 43Viral Infections and Immunology ResearchNeonatal and Maternal InfectionsRespiratory viral infections research

Severe Parechovirus 3 Infections in Young Infants—Kansas and Missouri, 2014

Open access
Midgley, Claire M, Jackson, Mary Anne, Selvarangan, Rangaraj, Franklin, Patrick, Holzschuh, Elizabeth L, Lloyd, Jennifer, Scaletta, Joseph, Straily, Anne +9 more·2018·Journal of the Pediatric Infectious Diseases Society

Abstract

BACKGROUND: Infection with parechovirus type 3 (PeV3) can cause severe neurologic and sepsis-like illness in young infants; clinical and epidemiologic descriptions have been limited. We aimed to characterize PeV3 illness and explore risk factors for acquisition in a cluster of neonatal cases at Children's Mercy Hospital in Kansas City, Missouri. METHODS: Cerebrospinal fluid specimens were obtained from infants aged <180 days who were hospitalized with sepsis-like illness or meningitis between June 1 and November 1, 2014. PeV-positive specimens were sequenced at the Centers for Disease Control and Prevention. We reviewed the medical and birth charts of the infants and performed face-to-face parent interviews. We analyzed characteristics according to infant age and intensive care admission status. RESULTS: We identified 35 cases of PeV infection in infants aged 5 to 56 days. Seven infants required intensive care (median age, 11 days vs 27 days among those who did not require intensive care; P = .0044). Six of these 7 infants had neurologic manifestations consistent with seizures, and all 6 of them were treated with acyclovir but subsequently tested negative for herpes simplex virus. Virus sequences formed 2 lineages, both of which were associated with severe illness. Half of the infants were reported to have household contacts who were ill during the week before onset. Infants aged ≤7 days at onset were more likely to have been delivered at the same hospital. CONCLUSIONS: PeV3 can cause severe neurologic illness in neonates, and younger infants are more likely to require intensive care. PeV3 should be considered along with herpes simplex virus and other pathogens when evaluating young infants with sepsis-like illness or meningitis. More widespread testing for PeV3 would enable us to gain a better understanding of the clinical scope and circulation of this virus.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jpids/pix010

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sepsis-like syndrome has been reported in 40-80% of HPeV (especially type 3) infections and 10-30% of EV infections in young infants.

    “Sepsis-like syndrome has been reported in 40–80% of HPeV (especially type 3) infections and 10–30% of EV infections in young infants (21–27).”

    From Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study (2024) · cites this paper as [21]

    The Conclusion (page not supplied) identifies PeV3 and enteroviruses as causes of sepsis-like illness in young infants. Neither it nor the retrieved Results and Discussion passages gives the claimed 40–80% HPeV or 10–30% EV frequencies; the reported percentages measure other outcomes or specimen detections. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • In children aged <3 months, approximately 90% of those with HPeV-positive CSF and >50% of those with EV-positive CSF showed normal CSF cell counts, consistent with previous reports' results.

    “In children aged <3 months, approximately 90% of those with HPeV-positive CSF and >50% of those with EV-positive CSF showed normal CSF cell counts, consistent with previous reports' results (21–25).”

    From Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study (2024) · cites this paper as [21]

    The Results report a lack of CSF pleocytosis among 35 hospitalized infants with PeV3-positive CSF, all aged 5–56 days, and say their cell counts were consistent with previous PeV reports. Our copy does not give an approximately 90% figure for normal CSF cell counts or report the claimed >50% figure for EV-positive CSF. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The secondary attack rates among family members have been reported to be lower for HPeV meningitis and encephalitis than for EV.

    “The secondary attack rates among family members have been reported to be lower for HPeV meningitis and encephalitis than or EV (19–21).”

    From Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study (2024) · cites this paper as [21]

    The Discussion reports that almost half of the infants had ill household contacts, but says comparison data from households without recognized PeV3 infection were unavailable. Neither that passage nor the passages found by searching for secondary attack rates and enterovirus comparisons reports family-member attack rates or compares HPeV with EV. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. [2]Tapia G Cinek O Witso E Longitudinal observation of parechovirus in stool samples from Norwegian infants J Med Virol 2008 80 1835 42 18712841
  2. [3]Karsch K Obermeier P Seeber L Human parechovirus infections associated with seizures and rash in infants and toddlers Pediatr Infect Dis 2015 34 1049 55 26181895
  3. [4]Verboon-Maciolek MA Groenendaal F Hahn CD Human parechovirus causes encephalitis with white matter injury in neonates Ann Neurol 2008 64 266 73 18825694
  4. [5]Yip CC Lo KL Que TL Epidemiology of human parechovirus, Aichi virus and salivirus in fecal samples from hospitalized children with gastroenteritis in Hong Kong Virol J 2014 11 182 25326707 PMC4283143
  5. [6]Wildenbeest JG Wolthers KC Straver B Pajkrt D Successful IVIg treatment of human parechovirus-associated dilated cardiomyopathy in an infant Pediatrics 2013 132 e243 7 23776125
  6. [7]Vergnano S Kadambari S Whalley K Characteristics and outcomes of human parechovirus infection in infants (2008–2012) Eur J Pediatr 2015 174 919 24 25573462
  7. [8]Selvarangan R Nzabi M Selvaraju SB Human parechovirus 3 causing sepsis-like illness in children from midwestern United States Pediatr Infect Dis J 2011 30 238 42 20948454
  8. [9]Benschop K Tomas X Serpenti C High prevalence of human parechovirus (HPeV) genotypes in the Amsterdam region and identification of specific HPeV variants by direct genotyping of stool samples J Clin Microbiol 2008 46 3965 70 18945833 PMC2593270
  9. [10]Khatami A McMullan BJ Webber M Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia Clin Infect Dis 2015 60 228 36 25301212
  10. [11]Sharp J Harrison CJ Puckett K Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations Pediatr Infect Dis J 2013 32 213 6 23042051 PMC4637937
  11. [12]Strenger V Diedrich S Boettcher S Nosocomial outbreak of parechovirus 3 infection among newborns, Austria, 2014 Emerg Infect Dis 2016 22 1631 4 27532333 PMC4994342
  12. [13]Zhao X Shi Y Xia Y Genome analysis revealed novel genotypes and recombination of the human parechoviruses prevalent in children in eastern China Gut Pathog 2016 8 52 27826360 PMC5100207
  13. [14]Cristanziano VD Böttcher S Diedrich S Detection and characterization of enteroviruses and parechoviruses in healthy people living in the South of Côte d'Ivoire J Clin Virol 2015 71 40 3 26370313
  14. [15]Baumgarte S de Souza Luna LK Grywna K Prevalence, types, and RNA concentrations of human parechoviruses, including a sixth parechovirus type, in stool samples from patients with acute enteritis J Clin Microbiol 2008 46 242 8 18057123 PMC2224249
  15. [16]Fischer TK Midgley S Dalgaard C Nielsen AY Human parechovirus infection, Denmark Emerg Infect Dis 2014 20 83 7 24377661 PMC3884717
  16. [17]Abedi GR Watson JT Pham H Enterovirus and human parechovirus surveillance—United States, 2009–2013 MMWR Morb Mortal Wkly Rep 2015 64 940 3 26334674
  17. [19]Selvaraju SB Nix WA Oberste MS Selvarangan R Optimization of a combined human parechovirus-enterovirus real-time reverse transcription-PCR assay and evaluation of a new parechovirus 3-specific assay for cerebrospinal fluid specimen testing J Clin Microbiol 2013 51 452 8 23175256 PMC3553926
  18. [20]Nix WA Maher K Pallansch MA Oberste MS Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing J Clin Virol 2010 48 202 7 20472496
  19. [21]Tamura K Stecher G Peterson D MEGA6: Molecular Evolutionary Genetics Analysis version 6.0 Mol Biol Evol 2013 30 2725 9 24132122 PMC3840312
  20. [22]Messacar K Breazeale G Wei Q Epidemiology and clinical characteristics of infants with human parechovirus or human herpes virus-6 detected in cerebrospinal fluid tested for enterovirus or herpes simplex virus J Med Virol 2015 87 829 35 25650069
  21. [23]Aizawa Y Suzuki Y Watanabe K Clinical utility of serum samples for human parechovirus type 3 infection in neonates and young infants: the 2014 epidemic in Japan J Infect 2015 72 223 32 26550926
  22. [24]Pariani E Pellegrinelli L Pugni L Two cases of neonatal human parechovirus 3 encephalitis Pediatr Infect Dis J 2014 33 1191 3 24853541
  23. [25]James SH Kimberlin DW Neonatal herpes simplex virus infection Infect Dis Clin North Am 2015 29 391 400 26154662
  24. [26]Britton PN Dale RC Nissen MD Parechovirus encephalitis and neurodevelopmental outcomes Pediatrics 2016 137 e20152848 26791970
  25. [27]Sedmak G Nix WA Jentzen J Infant deaths associated with human parechovirus infection in Wisconsin Clin Infect Dis 2010 50 357 61 20047496
  26. [28]Bissel SJ Auer RN Chiang CH Human parechovirus 3 meningitis and fatal leukoencephalopathy J Neuropathol Exp Neurol 2015 74 767 77 26115191
  27. [29]Nielsen NM Midgley SE Nielsen AC Severe human parechovirus infections in infants and the role of older siblings Am J Epidemiol 2016 183 664 70 26968944
  28. [30]Kolehmainen P Jaaskelainen A Blomqvist S Human parechovirus type 3 and 4 associated with severe infections in young children Pediatr Infect Dis J 2014 33 1109 13 25361406
  29. [31]Seo JH Yeom JS Youn HS Prevalence of human parechovirus and enterovirus in cerebrospinal fluid samples in children in Jinju, Korea Korean J Pediatr 2015 58 102 7 25861333 PMC4388971
  30. [32]Davis J Fairley D Christie S Human parechovirus infection in neonatal intensive care Pediatr Infect Dis J 2015 34 121 4 25126855
  31. [33]Cordey S L'Huillier AG Turin L Enterovirus and parechovirus viraemia in young children presenting to the emergency room: unrecognised and frequent J Clin Virol 2015 68 69 72 26071339
  32. [34]Aizawa Y Yamanaka T Watanabe K Asymptomatic children might transmit human parechovirus type 3 to neonates and young infants J Clin Virol 2015 70 105 8 26305831
  33. [35]Aizawa Y Watanabe K Oishi T Role of maternal antibodies in infants with severe diseases related to human parechovirus type 3 Emerg Infect Dis 2015 21 1966 72 26485714 PMC4622238
  34. [36]Berkovich S Pangan J Recoveries of virus from premature infants during outbreaks of respiratory disease: the relation of ECHO virus type 22 to disease of the upper and lower respiratory tract in the premature infant Bull N Y Acad Med 1968 44 377 87 5241248 PMC1750138
  35. [37]Birenbaum E Handsher R Kuint J Echovirus type 22 outbreak associated with gastro-intestinal disease in a neonatal intensive care unit Am J Perinatol 1997 14 469 73 9376008
  36. [38]Sharp J Bell J Harrison CJ Human parechovirus in respiratory specimens from children in Kansas City, Missouri J Clin Microbiol 2012 50 4111 3 23015672 PMC3502961
  37. [39]Wildenbeest JG Benschop KS Bouma-de Jongh S Prolonged shedding of human parechovirus in feces of young children after symptomatic infection Pediatr Infect Dis J 2016 35 580 3 26862672

Cited by

Sorted by citations

Authors
Midgley, C. M., Jackson, M. A., Selvarangan, R., Franklin, P., Holzschuh, E. L., Lloyd, J., Scaletta, J., Straily, A., Tubach, S., Willingham, A., Nix, W. A., Oberste, M. S., Harrison, C. J., Hunt, C., Turabelidze, G., Gerber, S. I., & Watson, J. T.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Children's Mercy Hospital (US)
  • Missouri Department of Health and Senior Services (US)
  • Kansas Department of Health and Environment (US)
  • National Center for Immunization and Respiratory Diseases (US)
Corresponding author
Midgley, Claire M
Venue
Journal of the Pediatric Infectious Diseases Society
Published
2017-03-29
Volume
7
Issue
2
Pages
104-112
ISSN
  • 2048-7193 (ISSN-L)
  • 2048-7207
OpenAlex
W2601077196
Cited by
43
References
2
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 7 · 2021: 5 · 2020: 9 · 2019: 7 · 2018: 5 · 2017: 1
FWCI
4.66
Type
journal article
Language
en
Open access
Locations
  • Journal of the Pediatric Infectious Diseases Society (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • US Centers for Disease Control and Prevention
  • Kansas Department of Health and Environment
  • Missouri Department of Health and Senior Services
  • Children’s Mercy Hospital
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Neonatal and Maternal Infections
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords
neonatal infection, sepsis-like illness, meningitis, neurologic manifestations, seizures, intensive care unit admission, household transmission, risk factors, Kansas City, Missouri
MeSH terms
Critical Care, Female, Humans, Infant, Infant, Newborn, Male, Meningitis, Viral, Missouri, Phylogeny, Picornaviridae Infections, Sepsis, Parechovirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review